A Study Evulating DA-302168S Tablets in Overweight/Obese Subjects

Clinical trial NCT06541730 · COMPLETED

Trial details

NCT number: NCT06541730
Sponsor: Chendu DIAO Pharmaceutical Group CO., LTD.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Overweight and Obesity

Start date: 2024-08-30
Primary completion: 2025-01-30
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.